CF
BIOS

Cantor Fitzgerald’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Cantor Fitzgerald’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,265,102
Closed -$13.2M – 721
2023
Q1 		$13.2M Sell
1,265,102
-157,102
-11% -$1.63M 0.28% 129
2022
Q4 		$14.6M Buy
1,422,204
+572,204
+67% +$5.81M 0.31% 109
2022
Q3 		$8.54M Buy
850,000
+50,000
+6% +$500K 0.19% 166
2022
Q2 		$7.95M Buy
800,000
+300,000
+60% +$2.98M 0.15% 183
2022
Q1 		$4.94M Buy
+500,000
New +$4.93M 0.37% 80

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
QL
Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Cantor Fitzgerald's BIOS Position: Q2 2023 in Review

Cantor Fitzgerald sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 1,265,102 shares — an estimated $13.2M sold.

Cantor Fitzgerald first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $14.6M in Q4 2022. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

  • Cantor Fitzgerald reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 1,265,102 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $13.2M.
  • Cantor Fitzgerald first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • Cantor Fitzgerald's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $14.6M in Q4 2022.
  • 32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.